Aquestive Therapeutics, Inc. short interest in 2025
In 2025, Aquestive Therapeutics, Inc.'s disclosed short interest ran from 12.93% of shares outstanding on 15 Jan 2025 to 19.79% on 31 Dec 2025, a change of +6.86 percentage points. The year's high was 19.79% on 31 Dec 2025 and its low 8.43% on 15 Aug 2025, averaging 11.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.35 days on 31 Dec 2025. Full history: Aquestive Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 12.93% (15 Jan 2025)
- End of year
- 19.79% (31 Dec 2025)
- Change
- +6.86 pp
- High
- 19.79% (31 Dec 2025)
- Low
- 8.43% (15 Aug 2025)
- Average
- 11.93%
- Highest days to cover
- 10.35 (31 Dec 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 12.93% | 6.75 | results (8-K) |
| 31 Jan 2025 | 12.16% | 9.42 | |
| 14 Feb 2025 | 10.94% | 3.76 | |
| 28 Feb 2025 | 10.94% | 6.03 | |
| 14 Mar 2025 | 10.34% | 7.58 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 10.14% | 7.45 | |
| 15 Apr 2025 | 9.98% | 7.06 | |
| 30 Apr 2025 | 9.51% | 9.54 | |
| 15 May 2025 | 9.95% | 4.71 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.27% | 8.70 | |
| 13 Jun 2025 | 12.14% | 6.64 | |
| 30 Jun 2025 | 11.31% | 7.29 | |
| 15 Jul 2025 | 10.12% | 8.63 | |
| 31 Jul 2025 | 9.55% | 8.75 | |
| 15 Aug 2025 | 8.43% | 5.80 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 9.30% | 6.49 | |
| 15 Sep 2025 | 8.90% | 2.64 | |
| 30 Sep 2025 | 11.61% | 2.41 | |
| 15 Oct 2025 | 12.29% | 3.80 | |
| 31 Oct 2025 | 14.78% | 5.42 | |
| 14 Nov 2025 | 15.73% | 5.89 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 16.25% | 7.19 | |
| 15 Dec 2025 | 17.97% | 10.05 | |
| 31 Dec 2025 | 19.79% | 10.35 |
See also: Aquestive Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.